News
1d
TipRanks on MSNPortage Biotech Reports Improved Fiscal Year Results
Portage Biotech ( ($PRTG) ) has released its Q4 earnings. Here is a breakdown of the information Portage Biotech presented to its investors.
PRTG’s web console provides a network overview showing the status of all sensors, and clicking on any of their icons next to the donut charts takes you to a filtered view.
PRTG will then instantly begin the monitoring process. If you look at Figure B, you'll notice that PRTG uses three graphs to display the data flow. In each one, ...
PRTG’s web console provides a network overview showing the status of all sensors, and clicking on any of their icons next to the donut charts takes you to a filtered view.
By John Vandermosten, CFA NASDAQ:PRTG READ THE FULL PRTG RESEARCH REPORT 3Q:24 Financial and Operational Results Since our initiation in January, Portage Biotech Inc. (NASDAQ:PRTG), has reported ...
By John Vandermosten, CFA NASDAQ:PRTG READ THE FULL PRTG RESEARCH REPORT We are initiating coverage of Portage Biotech Inc. (NASDAQ:PRTG) with a target price of $7.00 per share. This value is ...
PRTG closed Thursday's trading at $4.71, up 5.84%. In after-hours, the stock was up over 106% at $9.74. Sensei Biotherapeutics Inc. (SNSE) has reported favorable initial results from the dose ...
Explore Portage Biotech stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PRTG.
Shares of Portage Biotech Inc. (PRTG) have been struggling lately and have lost 8% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that ...
The current price Portage Biotech (PRTG) is trading at is $10.26, which is out of the analyst’s predicted range. Browse analyst ratings and price targets on all stocks. People Also Watch ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results